Related Experiment Video
Updated: Mar 31, 2026

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
Published on: February 25, 2016
Effects of p35 Mutations Associated with Mental Retardation on the Cellular Function of p35-CDK5
Shunsuke Takada1, Keiko Mizuno2, Taro Saito1
1Laboratory of Molecular Neuroscience, Department of Biological Sciences, Graduate School of Science, Tokyo Metropolitan University, Minami-Osawa, Hachioji, Tokyo, Japan.
Insights
Mutations in the p35 gene, a cyclin-dependent kinase 5 (CDK5) activator, were investigated for their role in mental retardation. The study found no significant biochemical or cellular differences between mutant and wild-type p35, suggesting these mutations do not cause the condition.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Cyclin-dependent kinase 5 (CDK5) is a neuronal Ser/Thr kinase crucial for brain development.
- The p35 protein (CDK5R1) is an essential activator subunit for CDK5.
- Disruptions in CDK5 or p35 are linked to impaired neuronal migration and mental retardation.
Purpose of the Study:
- To investigate the biochemical effects of p35 gene mutations found in patients with nonsyndromic mental retardation.
- To assess how these mutations impact p35 stability, CDK5 activation, and cellular localization.
- To evaluate the functional consequences of mutant p35 on neuronal migration and axon elongation.
Main Methods:
- Heterologous expression of wild-type and mutant p35 in cultured cells.
- Biochemical assays measuring p35 stability and CDK5 activation.
- Cellular localization studies of p35.
- Functional assays in primary neurons and embryonic brains examining axon elongation and neuronal migration.
Main Results:
- Mutant p35 proteins exhibited no significant differences in stability, CDK5 activation, or cellular localization compared to wild-type p35.
- No significant differences were observed in axon elongation in cultured primary neurons with mutant p35.
- Neuronal migration in embryonic brains was not significantly affected by the presence of mutant p35 forms.
Conclusions:
- The studied p35 mutations do not appear to alter key biochemical properties or cellular functions.
- These findings suggest that the investigated p35 gene mutations are unlikely to be the cause of nonsyndromic mental retardation.
- Further research may be needed to explore other potential genetic or molecular factors contributing to mental retardation.
Abstract:
p35 is an activation subunit of the cyclin-dependent kinase 5 (CDK5), which is a Ser/Thr kinase that is expressed predominantly in neurons. Disruption of the CDK5 or p35 (CDK5R1) genes induces abnormal neuronal layering in various regions of the mouse brain via impaired neuronal migration, which may be relevant for mental retardation in humans. Accordingly, mutations in the p35 gene were reported in patients with nonsyndromic mental retardation; however, their effect on the biochemical function of p35 has not been examined. Here, we studied the biochemical effect of mutant p35 on its known properties, i.e., stability, CDK5 activation, and cellular localization, using heterologous expression in cultured cells. We also examined the effect of the mutations on axon elongation in cultured primary neurons and migration of newborn neurons in embryonic brains. However, we did not detect any significant differences in the effects of the mutant forms of p35 compared with wild-type p35. Therefore, we conclude that these p35 mutations are unlikely to cause mental retardation.
More Related Videos
15:43Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Positive Regulator Molecules